Abiopharma

🔍 Cannon Gillian (Executive)

Company: CORCEPT THERAPEUTICS INC (CORT)

Report Date: 2025-09-04

Detailed Transactions and Holdings:

• Acquired 11,000 shares of Common Stock at $22.99 per share (Direct)
  Date: 2025-09-04 | Code: M | equity_swap_involved: false | shares_owned_after: 11,000.00 | transaction_form_type: 4
• Sold 3,607 shares of Common Stock at $70.13 per share (Direct)
  Date: 2025-09-04 | Code: F | equity_swap_involved: false | shares_owned_after: 7,393.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 11,000 shares of Stock option (right to buy) at $22.99 per share (Derivative)
  Date: 2025-09-04 | Code: M | Expires: 2030-12-01 | equity_swap_involved: false | shares_owned_after: 49,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These shares were withheld so the Reporting Person could satisfy the exercise price from a net (cashless) exercise of options.
• F2: Fully exercisable.
• REMARKS: The power of attorney under which this form was signed is on file with the Commission.